{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T23:03:43Z","timestamp":1781996623789,"version":"3.54.5"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>We have reviewed the literature to identify significant advances related to disease activity and damage in the idiopathic inflammatory myopathies (IIMs) from January 2019 to July 2020.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>New observations in the field from 2019 to 2020 have resulted in a better understanding of the clinical association and pathogenic origins of IIM. The use of patient-reported outcome measures and perspectives, identifying biomarkers and making better use of autoantibody testing are summarized. Basic sciences have led to an improved understanding of the role of NETosis in calcinosis, and of interferon type 1, in IIM. Preliminary insights are offered into Covid-19 in the setting of IIM, and the use of potential tools for monitoring disease remotely, which may assume larger importance for optimal disease management during a global pandemic. The wider exploration of newer imaging modalities and the use of nailfold capillaroscopy is a further step in better management of the condition.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The summarized research in IIM is a step forward in being able to further define, and to distinguish disease activity from damage, in order to potentially aid future clinical diagnosis and management in this challenging disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000749","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T21:08:09Z","timestamp":1599253689000},"page":"553-561","source":"Crossref","is-referenced-by-count":11,"title":["Monitoring disease activity and damage in adult and juvenile idiopathic inflammatory myopathy"],"prefix":"10.1097","volume":"32","author":[{"given":"Latika","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Chinoy","sequence":"additional","affiliation":[{"name":"Centre for Musculoskeletal Research, School of Biological Sciences, Manchester Academic Health Science Centre, The University of Manchester"},{"name":"National Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, The University of Manchester, Manchester"},{"name":"Department of Rheumatology, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41584-020-0412-6","article-title":"Can machine learning unravel the complex IIM spectrum?","volume":"16","author":"Lilleker","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/injr.injr_40_19","article-title":"Meeting report: MyoIN \u2013 Pan-India collaborative network for myositis research","volume":"14","author":"Gupta","year":"2019","journal-title":"Indian J Rheumatol"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/RHU.0000000000000715","article-title":"Can routine use of patient-reported outcomes help guide systemic sclerosis chronic disease care?","volume":"24","author":"Frech","year":"2018","journal-title":"J Clin Rheumatol"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s41927-019-0088-1","article-title":"A review of accelerometer-derived physical activity in the idiopathic inflammatory myopathies","volume":"3","author":"Oldroyd","year":"2019","journal-title":"BMC Rheumatol"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/0961203319860198","article-title":"The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts","volume":"28","author":"Frodlund","year":"2019","journal-title":"Lupus"},{"key":"R7-20230829","article-title":"The patients\u2019 perspective of important glucocorticoid effects: a nominal group study among patients with systemic lupus erythematosus and myositis","author":"Mirza","year":"2020","journal-title":"J Clin Rheumatol"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jaad.2019.01.028","article-title":"Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis","volume":"80","author":"Gaffney","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"e0217173","DOI":"10.1371\/journal.pone.0217173","article-title":"Reliability and validity of the German version of the Myositis Activities Profile (MAP) in patients with inflammatory myopathy","volume":"14","author":"Baschung","year":"2019","journal-title":"PLoS One"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mus.26859","article-title":"Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroups","volume":"62","author":"Oldroyd","year":"2020","journal-title":"Muscle Nerve"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semarthrit.2019.06.014","article-title":"Long-term outcomes in juvenile myositis patients","volume":"50","author":"Tsaltskan","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/1756-185X.13759","article-title":"Long-term outcome in children with juvenile dermatomyositis: a single-center study from North India","volume":"23","author":"Sharma","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3899\/jrheum.180526","article-title":"Effect on cardiac function of longstanding juvenile-onset mixed connective tissue disease: a controlled study","volume":"46","author":"Witczak","year":"2019","journal-title":"J Rheumatol"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/rheumatology\/key342","article-title":"Cardiorespiratory fitness in long-term juvenile dermatomyositis: a controlled, cross-sectional study of active\/inactive disease","volume":"58","author":"Berntsen","year":"2019","journal-title":"Rheumatology"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0962280217713233","article-title":"Modelling disease activity in juvenile dermatomyositis: a Bayesian approach","volume":"28","author":"van Dijkhuizen","year":"2019","journal-title":"Stat Methods Med Res"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bpobgyn.2019.10.004","article-title":"Pregnancy in myositis and scleroderma","volume":"64","author":"Munira","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R17-20230829","article-title":"Outcomes of pregnancy in women with inflammatory myositis: a retrospective cohort from India","author":"Gupta","year":"2019","journal-title":"J Clin Rheumatol"},{"key":"R19-20230829","article-title":"Combined case record forms for collaborative datasets of patients and controls of idiopathic inflammatory myopathies","author":"Mehta","year":"2020","journal-title":"Indian J Rheumatol"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/art.41078","article-title":"Neutrophil extracellular traps in tissue and periphery in juvenile dermatomyositis","volume":"72","author":"Duvvuri","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"102533","DOI":"10.1016\/j.autrev.2020.102533","article-title":"Calcinosis biomarkers in adult and juvenile dermatomyositis","volume":"19","author":"Chung","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12950-015-0075-2","article-title":"Adipokine gene expression in peripheral blood of adult and juvenile dermatomyositis patients and their relation to clinical parameters and disease activity measures","volume":"12","author":"Olazagasti","year":"2015","journal-title":"J Inflamm"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"e201800215","DOI":"10.26508\/lsa.201800215","article-title":"Expression of a constitutively active human STING mutant in hematopoietic cells produces an Ifnar1 -dependent vasculopathy in mice","volume":"2","author":"Martin","year":"2019","journal-title":"Life Sci Alliance"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13075-019-1905-z","article-title":"The RIG-I pathway is involved in peripheral T cell lymphopenia in patients with dermatomyositis","volume":"21","author":"Zhang","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/bjd.16917","article-title":"Aberrant activation of the type I interferon system may contribute to the pathogenesis of antimelanoma differentiation-associated gene 5 dermatomyositis","volume":"180","author":"Zhang","year":"2019","journal-title":"Br J Dermatol"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"e1193","DOI":"10.1212\/WNL.0000000000008128","article-title":"Identification of distinctive interferon gene signatures in different types of myositis","volume":"93","author":"Pinal-Fernandez","year":"2019","journal-title":"Neurology"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/art.40800","article-title":"Muscle expression of type I and type II interferons is increased in juvenile dermatomyositis and related to clinical and histologic features","volume":"71","author":"Moneta","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical associations of autoantibodies to a p155\/140 kDa doublet protein in juvenile dermatomyositis","volume":"47","author":"Gunawardena","year":"2008","journal-title":"Rheumatology"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","article-title":"A novel autoantibody to a 155-kd protein is associated with dermatomyositis","volume":"54","author":"Targoff","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/key357","article-title":"The temporal relationship between cancer and adult onset antitranscriptional intermediary factor 1 antibody-positive dermatomyositis","volume":"58","author":"Oldroyd","year":"2019","journal-title":"Rheumatology"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/art.40895","article-title":"The IgG2 isotype of anti\u2013transcription intermediary factor 1\u03b3 autoantibodies is a biomarker of cancer and mortality in adult dermatomyositis","volume":"71","author":"Aussy","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R33-20230829","first-page":"928","article-title":"[Three cases report of juvenile dermatomyositis with positive antimelanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review]","volume":"57","author":"Hou","year":"2019","journal-title":"Chin J Pediatr"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"e15578","DOI":"10.1097\/MD.0000000000015578","article-title":"Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis\/dermatomyositis","volume":"98","author":"Temmoku","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00296-019-04255-2","article-title":"Liver dysfunction in antimelanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis","volume":"39","author":"Nagashima","year":"2019","journal-title":"Rheumatol Int"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/1346-8138.14758","article-title":"Clinical value of 18 F-fluorodeoxyglucose positron emission tomography\/computed tomography for interstitial lung disease and myositis in patients with dermatomyositis","volume":"46","author":"Motegi","year":"2019","journal-title":"J Dermatol"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"6708","DOI":"10.1007\/s00330-019-06302-9","article-title":"Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis","volume":"29","author":"Martis","year":"2019","journal-title":"Eur Radiol"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/mus.26731","article-title":"Thigh muscle MRI findings in myopathy associated with antimitochondrial antibody","volume":"61","author":"Minamiyama","year":"2020","journal-title":"Muscle Nerve"},{"key":"R39-20230829","first-page":"633","article-title":"Correlation between quantitative and semiquantitative magnetic resonance imaging and histopathology findings in dermatomyositis","volume":"37","author":"Milisenda","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"R40-20230829","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2020.02.009","article-title":"Severe axial and pelvifemoral muscle damage in immune-mediated necrotizing myopathy evaluated by whole-body MRI","author":"Landon-Cardinal","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00296-019-04254-3","article-title":"Intravenous human immunoglobulin and\/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies","volume":"39","author":"de Souza","year":"2019","journal-title":"Rheumatol Int"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/acr.23687","article-title":"Association between nailfold capillary density and pulmonary and cardiac involvement in medium to longstanding juvenile dermatomyositis","volume":"71","author":"Barth","year":"2019","journal-title":"Arthritis Care Res"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00296-019-04427-0","article-title":"Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic","volume":"40","author":"Bernardino","year":"2020","journal-title":"Rheumatol Int"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s10067-019-04537-x","article-title":"Nailfold capillary changes in adult new-onset dermatomyositis: a prospective cross-sectional study","volume":"38","author":"Miossi","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R45-20230829","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217522","article-title":"Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis","author":"Megremis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R46-20230829","article-title":"Myositis as a manifestation of SARS-CoV-2","author":"Beydon","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R47-20230829","article-title":"Response to: \u2018Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort\u2019 by Costa et al","author":"Gupta","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R48-20230829","article-title":"Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis\/dermatomyositis-interstitial lung disease","author":"Matsuda","year":"2019","journal-title":"Rheumatology"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/art.40881","article-title":"Galectin-9 and CXCL10 as biomarkers for disease activity in juvenile dermatomyositis: a longitudinal cohort study and multicohort validation","volume":"71","author":"Wienke","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/1346-8138.15117","article-title":"Elevated serum B-cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease","volume":"46","author":"Matsushita","year":"2019","journal-title":"J Dermatol"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cyto.2018.12.023","article-title":"Pro-inflammatory S100A11 is elevated in inflammatory myopathies and reflects disease activity and extramuscular manifestations in myositis","volume":"116","author":"Andr\u00e9s Cerezo","year":"2019","journal-title":"Cytokine"},{"key":"R52-20230829","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1080\/14397595.2018.1548918","article-title":"Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis","volume":"29","author":"Nishioka","year":"2019","journal-title":"Mod Rheumatol"},{"key":"R53-20230829","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/14397595.2018.1553488","article-title":"KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis\/dermatomyositis, but is not a short-term disease-activity biomarker","volume":"29","author":"Hanaoka","year":"2019","journal-title":"Mod Rheumatol"},{"key":"R54-20230829","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/rheumatology\/key420","article-title":"Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease","volume":"58","author":"Takanashi","year":"2019","journal-title":"Rheumatology"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/art.41096","article-title":"Circulating interferon-\u03b1 measured with a highly sensitive assay as a biomarker for juvenile inflammatory myositis activity: comment on the article by Mathian et al","volume":"72","author":"Melki","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R57-20230829","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/art.41075","article-title":"Proinflammatory histidyl\u2013transfer RNA synthetase\u2013specific CD 4+ T cells in the blood and lungs of patients with idiopathic inflammatory myopathies","volume":"72","author":"Galindo-Feria","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R58-20230829","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kez252","article-title":"Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathies","author":"Wilkinson","year":"2019","journal-title":"Rheumatology"},{"key":"R59-20230829","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jneuroim.2019.04.014","article-title":"Mass cytometry reveals an impairment of B cell homeostasis in antisynthetase syndrome","volume":"332","author":"Dzangu\u00e9-Tchoupou","year":"2019","journal-title":"J Neuroimmunol"},{"key":"R60-20230829","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.autrev.2019.02.003","article-title":"CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis","volume":"18","author":"Dzangu\u00e9-Tchoupou","year":"2019","journal-title":"Autoimmun Rev"},{"key":"R61-20230829","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/03009742.2018.1530371","article-title":"Peripheral blood lymphocyte subset repertoires are biased and reflect clinical features in patients with dermatomyositis","volume":"48","author":"Sasaki","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"R62-20230829","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/rheumatology\/kez185","article-title":"Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD","volume":"58","author":"Horiike","year":"2019","journal-title":"Rheumatology"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T07:14:38Z","timestamp":1693293278000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000749","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]}}}